- Home
- LYEL vs RELX Comparison
LYEL vs RELX Comparison
Compare LYEL & RELX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LYEL
- RELX
- Stock Information
- Founded
- LYEL 2018
- RELX 1903
- Country
- LYEL United States
- RELX United Kingdom
- Employees
- LYEL N/A
- RELX N/A
- Industry
- LYEL Biotechnology: Pharmaceutical Preparations
- RELX Business Services
- Sector
- LYEL Health Care
- RELX Consumer Discretionary
- Exchange
- LYEL Nasdaq
- RELX Nasdaq
- Market Cap
- LYEL 207.7M
- RELX 97.3B
- IPO Year
- LYEL 2021
- RELX N/A
- Fundamental
- Price
- LYEL $9.45
- RELX $52.91
- Analyst Decision
- LYEL Sell
- RELX Strong Buy
- Analyst Count
- LYEL 2
- RELX 2
- Target Price
- LYEL $15.00
- RELX N/A
- AVG Volume (30 Days)
- LYEL 125.9K
- RELX 923.6K
- Earning Date
- LYEL 08-06-2025
- RELX 07-25-2025
- Dividend Yield
- LYEL N/A
- RELX 1.14%
- EPS Growth
- LYEL N/A
- RELX 10.15
- EPS
- LYEL N/A
- RELX 1.29
- Revenue
- LYEL $65,000.00
- RELX $11,810,658,884.00
- Revenue This Year
- LYEL N/A
- RELX $9.12
- Revenue Next Year
- LYEL N/A
- RELX $7.22
- P/E Ratio
- LYEL N/A
- RELX $40.20
- Revenue Growth
- LYEL N/A
- RELX 2.98
- 52 Week Low
- LYEL $7.65
- RELX $43.45
- 52 Week High
- LYEL $35.80
- RELX $56.33
- Technical
- Relative Strength Index (RSI)
- LYEL 52.07
- RELX 45.40
- Support Level
- LYEL $9.11
- RELX $53.13
- Resistance Level
- LYEL $9.83
- RELX $53.93
- Average True Range (ATR)
- LYEL 0.58
- RELX 0.53
- MACD
- LYEL 0.01
- RELX -0.03
- Stochastic Oscillator
- LYEL 61.75
- RELX 35.40
About LYEL Lyell Immunopharma Inc.
Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.
About RELX RELX PLC PLC
RELX is a global provider of information-based analytics and decision tools for professional and business customers in various industries. The company serves sectors such as science and medical research, risk management, and legal. In addition, RELX organizes large-scale digital and face-to-face events such as industry trade shows. Around 60% of revenue is generated in North America and about 20% in Europe.